Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 6OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Drug-Related Side Effects and Adverse Reactions 1Atrophy 1

Interventions

Oxaliplatin 10Fluorouracil 6Irinotecan 5Docetaxel 5Capecitabine 5tislelizumab 4S 1 (combination) 4Paclitaxel 4Endoscopic Mucosal Resection 4XELOX 3Levoleucovorin 3Laparoscopy 3Folfox protocol 3sintilimab 2apatinib 2Proton Pump Inhibitors 2Gastroenterostomy 2Gastrectomy 2Clarithromycin 2Chemotherapy, Adjuvant 2Amoxicillin 2vactosertib 1titanium silicide 1pembrolizumab 1lenvatinib 1durvalumab 1bismuth tripotassium dicitrate 1anlotinib 1Trastuzumab 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Stomach Neoplasms × Amoxicillin × Clear all
NCT06216639 2024-02-09

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

National Institute of Public Health, Slovenia

Unknown
2,000 enrolled
Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02407119 2023-11-09

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

National Cancer Center, Korea

Phase 3 Active not recruiting
470 enrolled
Gastrointestinal

Atrophy, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡